Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India limits e...
Main Authors: | Mathew John, Ekaterina Koledova, Kanakatte Mylariah Prasanna Kumar, Harshal Chaudhari |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/2967578 |
Similar Items
-
Incidence trends for childhood type 1 diabetes in India
by: Kanakatte Mylariah Prasanna Kumar
Published: (2015-01-01) -
Improving diabetes care for children with type 1 diabetes from poor families: Changing diabetes® in children program, India
by: Kanakatte Mylariah Prasanna Kumar
Published: (2014-01-01) -
Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency.
by: Paula van Dommelen, et al.
Published: (2018-01-01) -
Evolving landscape of multiple sclerosis in India: Challenges in the management
by: Sudhir Kumar, et al.
Published: (2018-01-01) -
Managing Transition in Patients Treated with Growth Hormone
by: Berthold P. Hauffa, et al.
Published: (2017-12-01)